These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9342776)

  • 1. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia.
    Ferré S
    Psychopharmacology (Berl); 1997 Sep; 133(2):107-20. PubMed ID: 9342776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia.
    Ferré S; O'Connor WT; Snaprud P; Ungerstedt U; Fuxe K
    Neuroscience; 1994 Dec; 63(3):765-73. PubMed ID: 7898676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions.
    Akhondzadeh S; Shasavand E; Jamilian H; Shabestari O; Kamalipour A
    J Clin Pharm Ther; 2000 Apr; 25(2):131-7. PubMed ID: 10849191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia.
    Fuxe K; Ferré S; Zoli M; Agnati LF
    Brain Res Brain Res Rev; 1998 May; 26(2-3):258-73. PubMed ID: 9651540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.
    Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S
    Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.
    Ferré S; Fredholm BB; Morelli M; Popoli P; Fuxe K
    Trends Neurosci; 1997 Oct; 20(10):482-7. PubMed ID: 9347617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
    Lillrank SM; Lipska BK; Weinberger DR; Fredholm BB; Fuxe K; Ferré S
    Neurochem Int; 1999 Mar; 34(3):235-44. PubMed ID: 10355490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.
    Mayfield RD; Jones BA; Miller HA; Simosky JK; Larson GA; Zahniser NR
    Synapse; 1999 Sep; 33(4):274-81. PubMed ID: 10421708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation.
    Xie X; Ramkumar V; Toth LA
    Comp Med; 2007 Dec; 57(6):538-45. PubMed ID: 18246865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine-dopamine interactions revealed in knockout mice.
    Salmi P; Chergui K; Fredholm BB
    J Mol Neurosci; 2005; 26(2-3):239-44. PubMed ID: 16012197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
    Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K
    Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells.
    Salim H; Ferré S; Dalal A; Peterfreund RA; Fuxe K; Vincent JD; Lledo PM
    J Neurochem; 2000 Jan; 74(1):432-9. PubMed ID: 10617149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of effects of adenosine and dopamine on modification of synapses in striato-nigral and striato-pallidal neurons].
    Sil'kis IG
    Ross Fiziol Zh Im I M Sechenova; 2001 Feb; 87(2):155-69. PubMed ID: 11296702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.
    López-Cruz L; San Miguel N; Carratalá-Ros C; Monferrer L; Salamone JD; Correa M
    Neuropharmacology; 2018 Aug; 138():349-359. PubMed ID: 29408363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum.
    Ferré S; Popoli P; Rimondini R; Reggio R; Kehr J; Fuxe K
    Neuropharmacology; 1999 Jan; 38(1):129-40. PubMed ID: 10193904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum.
    Díaz-Cabiale Z; Hurd Y; Guidolin D; Finnman UB; Zoli M; Agnati LF; Vanderhaeghen JJ; Fuxe K; Ferré S
    Neuroreport; 2001 Jul; 12(9):1831-4. PubMed ID: 11435907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.
    Kurokawa M; Koga K; Kase H; Nakamura J; Kuwana Y
    J Neurochem; 1996 May; 66(5):1882-8. PubMed ID: 8780014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.
    Fuxe K; Ferré S; Genedani S; Franco R; Agnati LF
    Physiol Behav; 2007 Sep; 92(1-2):210-7. PubMed ID: 17572452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.
    Fuxe K; Borroto-Escuela DO; Tarakanov AO; Romero-Fernandez W; Ferraro L; Tanganelli S; Perez-Alea M; Di Palma M; Agnati LF
    Prog Brain Res; 2014; 211():113-39. PubMed ID: 24968778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.